177 related articles for article (PubMed ID: 34069252)
1. Mutation Profile of Aggressive Pheochromocytoma and Paraganglioma with Comparison of TCGA Data.
Choi YM; Lim J; Jeon MJ; Lee YM; Sung TY; Hong EG; Lee JY; Jang SJ; Kim WG; Song DE; Chun SM
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34069252
[TBL] [Abstract][Full Text] [Related]
2. PD-L1 expression and association with genetic background in pheochromocytoma and paraganglioma.
Hadrava Vanova K; Uher O; Meuter L; Ghosal S; Talvacchio S; Patel M; Neuzil J; Pacak K
Front Oncol; 2022; 12():1045517. PubMed ID: 36439433
[TBL] [Abstract][Full Text] [Related]
3. Mutational Profile and Potential Molecular Therapeutic Targets of Pheochromocytoma.
Ma X; Ling C; Zhao M; Wang F; Cui Y; Wen J; Ji Z; Zhang C; Chen S; Tong A; Li Y
Front Endocrinol (Lausanne); 2022; 13():921645. PubMed ID: 35966080
[TBL] [Abstract][Full Text] [Related]
4. Domain landscapes of somatic NF1 mutations in pheochromocytoma and paraganglioma.
Tabebi M; Frikha F; Volpe M; Gimm O; Söderkvist P
Gene; 2023 Jul; 872():147432. PubMed ID: 37062455
[TBL] [Abstract][Full Text] [Related]
5. Co-occurrence of mutations in
Mellid S; Gil E; Letón R; Caleiras E; Honrado E; Richter S; Palacios N; Lahera M; Galofré JC; López-Fernández A; Calatayud M; Herrera-Martínez AD; Galvez MA; Matias-Guiu X; Balbín M; Korpershoek E; Lim ES; Maletta F; Lider S; Fliedner SMJ; Bechmann N; Eisenhofer G; Canu L; Rapizzi E; Bancos I; Robledo M; Cascón A
Front Endocrinol (Lausanne); 2022; 13():1070074. PubMed ID: 36760809
[TBL] [Abstract][Full Text] [Related]
6. Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients.
Currás-Freixes M; Inglada-Pérez L; Mancikova V; Montero-Conde C; Letón R; Comino-Méndez I; Apellániz-Ruiz M; Sánchez-Barroso L; Aguirre Sánchez-Covisa M; Alcázar V; Aller J; Álvarez-Escolá C; Andía-Melero VM; Azriel-Mira S; Calatayud-Gutiérrez M; Díaz JÁ; Díez-Hernández A; Lamas-Oliveira C; Marazuela M; Matias-Guiu X; Meoro-Avilés A; Patiño-García A; Pedrinaci S; Riesco-Eizaguirre G; Sábado-Álvarez C; Sáez-Villaverde R; Sainz de Los Terreros A; Sanz Guadarrama Ó; Sastre-Marcos J; Scolá-Yurrita B; Segura-Huerta Á; Serrano-Corredor Mde L; Villar-Vicente MR; Rodríguez-Antona C; Korpershoek E; Cascón A; Robledo M
J Med Genet; 2015 Oct; 52(10):647-56. PubMed ID: 26269449
[TBL] [Abstract][Full Text] [Related]
7. Genetic and Clinical Profiles of Pheochromocytoma and Paraganglioma: A Single Center Study.
Ma X; Li M; Tong A; Wang F; Cui Y; Zhang X; Zhang Y; Chen S; Li Y
Front Endocrinol (Lausanne); 2020; 11():574662. PubMed ID: 33362715
[TBL] [Abstract][Full Text] [Related]
8. Mutational profile and genotype/phenotype correlation of non-familial pheochromocytoma and paraganglioma.
Albattal S; Alswailem M; Moria Y; Al-Hindi H; Dasouki M; Abouelhoda M; Alkhail HA; Alsuhaibani E; Alzahrani AS
Oncotarget; 2019 Oct; 10(57):5919-5931. PubMed ID: 31666924
[TBL] [Abstract][Full Text] [Related]
9. Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma/paraganglioma in Korea.
Kim JH; Seong MW; Lee KE; Choi HJ; Ku EJ; Bae JH; Park SS; Choi SH; Kim SW; Shin C; Kim SY
Clin Genet; 2014 Nov; 86(5):482-6. PubMed ID: 24134185
[TBL] [Abstract][Full Text] [Related]
10. Targeted next-generation sequencing detects rare genetic events in pheochromocytoma and paraganglioma.
Ben Aim L; Pigny P; Castro-Vega LJ; Buffet A; Amar L; Bertherat J; Drui D; Guilhem I; Baudin E; Lussey-Lepoutre C; Corsini C; Chabrier G; Briet C; Faivre L; Cardot-Bauters C; Favier J; Gimenez-Roqueplo AP; Burnichon N
J Med Genet; 2019 Aug; 56(8):513-520. PubMed ID: 30877234
[TBL] [Abstract][Full Text] [Related]
11. Investigating the role of somatic sequencing platforms for phaeochromocytoma and paraganglioma in a large UK cohort.
Winzeler B; Tufton N; S Lim E; Challis BG; Park SM; Izatt L; Carroll PV; Velusamy A; Hulse T; Whitelaw BC; Martin E; Rodger F; Maranian M; Clark GR; A Akker S; Maher ER; Casey RT
Clin Endocrinol (Oxf); 2022 Oct; 97(4):448-459. PubMed ID: 34870338
[TBL] [Abstract][Full Text] [Related]
12. Study of germline mutations in patients with pheochromocytoma and paraganglioma in a tertiary level university hospital: Which patients have been studied and what results have been found?
Jiménez CM; Quílez RP; Gonzalvo C; Pinés P; Olmos M; Lamas C
Endocrinol Diabetes Nutr (Engl Ed); 2018 Nov; 65(9):508-514. PubMed ID: 30172768
[TBL] [Abstract][Full Text] [Related]
13. Spatiotemporal Heterogeneity Characterizes the Genetic Landscape of Pheochromocytoma and Defines Early Events in Tumorigenesis.
Crona J; Backman S; Maharjan R; Mayrhofer M; Stålberg P; Isaksson A; Hellman P; Björklund P
Clin Cancer Res; 2015 Oct; 21(19):4451-60. PubMed ID: 25991818
[TBL] [Abstract][Full Text] [Related]
14. HRAS mutation prevalence and associated expression patterns in pheochromocytoma.
Stenman A; Welander J; Gustavsson I; Brunaud L; Bäckdahl M; Söderkvist P; Gimm O; Juhlin CC; Larsson C
Genes Chromosomes Cancer; 2016 May; 55(5):452-9. PubMed ID: 26773571
[TBL] [Abstract][Full Text] [Related]
15. Genotype-phenotype correlations in pheochromocytoma and paraganglioma: a systematic review and individual patient meta-analysis.
Crona J; Lamarca A; Ghosal S; Welin S; Skogseid B; Pacak K
Endocr Relat Cancer; 2019 May; 26(5):539-550. PubMed ID: 30893643
[TBL] [Abstract][Full Text] [Related]
16. Risk of metastatic pheochromocytoma and paraganglioma in
Lee H; Jeong S; Yu Y; Kang J; Sun H; Rhee JK; Kim YH
J Med Genet; 2020 Apr; 57(4):217-225. PubMed ID: 31649053
[TBL] [Abstract][Full Text] [Related]
17. PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics.
Currás-Freixes M; Piñeiro-Yañez E; Montero-Conde C; Apellániz-Ruiz M; Calsina B; Mancikova V; Remacha L; Richter S; Ercolino T; Rogowski-Lehmann N; Deutschbein T; Calatayud M; Guadalix S; Álvarez-Escolá C; Lamas C; Aller J; Sastre-Marcos J; Lázaro C; Galofré JC; Patiño-García A; Meoro-Avilés A; Balmaña-Gelpi J; De Miguel-Novoa P; Balbín M; Matías-Guiu X; Letón R; Inglada-Pérez L; Torres-Pérez R; Roldán-Romero JM; Rodríguez-Antona C; Fliedner SMJ; Opocher G; Pacak K; Korpershoek E; de Krijger RR; Vroonen L; Mannelli M; Fassnacht M; Beuschlein F; Eisenhofer G; Cascón A; Al-Shahrour F; Robledo M
J Mol Diagn; 2017 Jul; 19(4):575-588. PubMed ID: 28552549
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel SDHB c.563 T > C mutation responsible for Paraganglioma syndrome and genetic analysis of the SDHB gene in China: a case report.
Chen H; Yao W; He Q; Yu X; Bian B
BMC Med Genet; 2020 May; 21(1):116. PubMed ID: 32460727
[TBL] [Abstract][Full Text] [Related]
19. Next-generation panel sequencing identifies
Gieldon L; Masjkur JR; Richter S; Därr R; Lahera M; Aust D; Zeugner S; Rump A; Hackmann K; Tzschach A; Januszewicz A; Prejbisz A; Eisenhofer G; Schrock E; Robledo M; Klink B
Eur J Endocrinol; 2018 Feb; 178(2):K1-K9. PubMed ID: 29158289
[TBL] [Abstract][Full Text] [Related]
20. Pheochromocytoma and Paraganglioma in Children and Adolescents: Experience of the French Society of Pediatric Oncology (SFCE).
de Tersant M; Généré L; Freyçon C; Villebasse S; Abbas R; Barlier A; Bodet D; Corradini N; Defachelles AS; Entz-Werle N; Fouquet C; Galmiche L; Gandemer V; Lacour B; Mansuy L; Orbach D; Pluchart C; Réguerre Y; Rigaud C; Sarnacki S; Sirvent N; Stephan JL; Thebaud E; Gimenez-Roqueplo AP; Brugières L
J Endocr Soc; 2020 May; 4(5):bvaa039. PubMed ID: 32432211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]